Dermata Therapeutics, Inc. (DRMA) stock gained in the Pre-market; here is why?
Shariq Khan
February 10, 2022
Dermata Therapeutics, Inc. (DRMA) gained in the pre-market after submitting two-sec filings. DRMA values at $1.40, gaining more than 30% compared to yesterday’s closing price.